GEN Exclusives

More »

GEN Poll

More »
Apr 06, 2012

Biofacility Construction

Pfizer, Novartis, and Shire are among nearly a dozen biopharma companies, research institutions, and developers building a combined 3.5 million plus square feet of lab and office space totaling more than $2 billion across Massachusetts. The list also includes research institutions like Broad Institute and developers like Alexandria Real Estate Equities. While companies are growing, with aided incentives like tax breaks, Massachusetts will face increasing competition from global emerging markets with their own incentives such as lower wages and less regulatory red tape.

How confident are you that Massachusetts can sustain its biopharma construction boom?

Very
 
  60.3%
Somewhat
 
  23.8%
Not Very
 
  11.1%
Undecided
 
  4.8%

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

Tackling the Global Problem of Fake Medicines

Policy proposals to address the growing global problem of fake medicines include a global agreement, similar to the Framework Convention on Tobacco Control, and stricter national laws to prosecute those who knowingly sell counterfeit medicines. Do you think these steps will be successful?

More »